Get started
Author

Arno N. Floore

Observed names: A Floore, A N Floore, A. Floore, A. N Floore, A. N. Floore, A.N. Floore, Arno Floore, Arno N Floore, Floore, A
Observed institutions: Guy's Hospital, Inserm, University of Milan, The Royal Free Hospital, Institut Jules Bordet, Institut Gustave Roussy, Hvidovre Hospital, Slotervaartziekenhuis, John Radcliffe Hospital, Karolinska Institutet, The Netherlands Cancer Institute, Agendia (Netherlands), Medisch Centrum Alkmaar, Self-screen BV (Netherlands), University College London, European Institute of Oncology
ORCID: 0000-0002-5835-2688
Observed ORCID: 0000-0002-5835-2688
OpenAlex ID: A5008438893
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
2006 · Marc Buyse, Sherene Loi, et al. · JNCI Journal of the National Cancer Institute · 1,240
PDF
Converting a breast cancer microarray signature into a high-throughput diagnostic test
2006 · Annuska M Glas, Arno Floore, et al. · BMC Genomics · 501
PDF
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
2008 · Stella Mook, Marjanka K. Schmidt, et al. · Breast Cancer Research and Treatment · 300
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
2007 · Jolien M Bueno-de-Mesquita, Wim H van Harten, et al. · The Lancet Oncology · 274
Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer
2004 · Rob Michalides, Alexander Griekspoor, et al. · Cancer Cell · 269
PDF
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
2000 · Annegien Broeks, Jos H.M. Urbanus, et al. · The American Journal of Human Genetics · 247
PDF
Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown Primary
2008 · Hugo M. Horlings, Ryan K. van Laar, et al. · Journal of Clinical Oncology · 184
Validation of 70-gene prognosis signature in node-negative breast cancer
2008 · J. M. Bueno-de-Mesquita, S. C. Linn, et al. · Breast Cancer Research and Treatment · 183
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
2009 · S. Mook, M.K. Schmidt, et al. · Annals of Oncology · 155
An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
2008 · Paul Roepman, Jacek Jassem, et al. · Clinical Cancer Research · 144
Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
2020 · Jesper Bonde, Arno Floore, et al. · International Journal of Cancer · 140
PDF
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
2008 · J Bridgewater, R van Laar, et al. · British Journal of Cancer · 101
PDF
FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
2019 · Frederique J. Vink, Chris J.L.M. Meijer, et al. · International Journal of Cancer · 85
PDF
Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary
2009 · Ryan K. van Laar, Xiao‐Jun Ma, et al. · International Journal of Cancer · 55
Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
2007 · Robert A Ach, Arno Floore, et al. · BMC Genomics · 54
PDF
Classification of high‐grade cervical intraepithelial neoplasia by p16 ink4a , Ki‐67, HPV E4 and FAM19A4 / miR124 ‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management
2021 · Frederique J. Vink, Stèfanie Dick, et al. · International Journal of Cancer · 53
Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?
2004 · Csilla I. Szabo, Mieke Schutte, et al. · Cancer Research · 50
Equivalence of MammaPrint array types in clinical trials and diagnostics
2016 · Inès Beumer, Anke Witteveen, et al. · Breast Cancer Research and Treatment · 49
PDF
Intra‐ and inter‐laboratory agreement of the FAM19A4/mir124‐2 methylation test: Results from an international study
2019 · Arno Floore, Albertus Hesselink, et al. · Journal of Clinical Laboratory Analysis · 35
PDF
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
2022 · Frederique J Vink, Chris J L M Meijer, et al. · Clinical Infectious Diseases · 32
PDF
Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine
2021 · Laura Téblick, Severien Van Keer, et al. · Molecules · 32
PDF
IVS10–6T>G, an ancient ATM germline mutation linked with breast cancer
2003 · Annegien Broeks, Jos H. M. Urbanus, et al. · Human Mutation · 29
Performance Characteristics of the MammaPrint ® Breast Cancer Diagnostic Gene Signature
2013 · Leonie JM Delahaye, Diederik Wehkamp, et al. · Personalized Medicine · 28
Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
2013 · Floris H. Groenendijk, Wilbert Zwart, et al. · Breast Cancer Research and Treatment · 27
PDF
Comparison of histopathological and gene expression-based typing of cancer of unknown primary
2009 · Lars Morawietz, Arno Floore, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 23
Works count: 47
Citation count: 4,392
H-index: 24
I10-index: 30
Year
Topic
Type